Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | -21.21%52 | -21.21%52 | -21.21%52 | -23.26%264 | -23.26%66 | -23.26%66 | -23.26%66 | -23.26%66 | -21.82%344 | -21.82%86 |
| Gross profit | 21.21%-52 | 21.21%-52 | 21.21%-52 | 23.26%-264 | 23.26%-66 | 23.26%-66 | 23.26%-66 | 23.26%-66 | 21.82%-344 | 21.82%-86 |
| Operating expense | 330.46%470.27K | 25.56%147.91K | -0.35%162.33K | -28.75%644.67K | 45.82%254.72K | -61.58%109.25K | -45.06%117.8K | -29.58%162.9K | 0.23%904.81K | -46.39%174.68K |
| Selling and administrative expenses | 381.63%435.93K | 8.08%108.57K | -2.08%134.5K | -32.01%561.84K | 58.82%233.52K | -66.61%90.51K | -50.09%100.45K | -33.65%137.36K | 0.50%826.4K | -48.46%147.03K |
| -Selling and marketing expense | 1,522.54%12.02K | -75.10%7.36K | -85.17%5.42K | -77.45%75.59K | -91.87%8.71K | -98.98%741 | -65.60%29.56K | -47.49%36.58K | 96.35%335.17K | 148.75%107.15K |
| -General and administrative expense | 372.22%423.9K | 42.77%101.21K | 28.08%129.07K | -1.01%486.25K | 463.76%224.81K | -54.82%89.77K | -38.53%70.89K | -26.63%100.78K | -24.61%491.23K | -83.53%39.88K |
| Provision for doubtful accounts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Other taxes | --0 | --0 | -71.89%1.26K | -78.44%4.49K | --0 | --0 | --0 | -20.73%4.49K | --20.83K | --16.16K |
| Other operating expenses | 83.28%34.34K | 126.83%39.35K | 26.23%26.57K | 36.02%78.34K | 84.56%21.2K | 41.11%18.74K | 22.41%17.35K | 12.84%21.05K | -15.26%57.59K | -59.12%11.49K |
| Operating profit | -330.25%-470.32K | -25.54%-147.97K | 0.36%-162.39K | 28.75%-644.93K | -45.79%-254.79K | 61.57%-109.31K | 45.06%-117.87K | 29.58%-162.97K | -0.22%-905.16K | 46.38%-174.77K |
| Net non-operating interest income (expenses) | 481.90%4.89K | 460.43%5.69K | 258.59%10.96K | 31.18%14.52K | 33,041.38%9.61K | -71.26%840 | -50.87%1.02K | -49.50%3.06K | 48.17%11.07K | -99.18%29 |
| Non-operating interest income | 481.90%4.89K | 460.43%5.69K | 258.59%10.96K | 31.18%14.52K | 33,041.38%9.61K | -71.26%840 | -50.87%1.02K | -49.50%3.06K | 48.17%11.07K | -99.18%29 |
| Other net income (expenses) | 133.33%28.42K | 0.00%-85.25K | 120.00%28.42K | 51.54%-255.74K | 100.00%56.83K | 18.84%-85.25K | -66.85%-85.25K | 64.48%-142.08K | -178.19%-527.7K | -95.94%28.42K |
| Gain on sale of security | 133.33%28.42K | 0.00%-85.25K | 120.00%28.42K | 51.54%-255.74K | 100.00%56.83K | 18.84%-85.25K | -66.85%-85.25K | 64.48%-142.08K | -250.77%-527.7K | -95.63%28.42K |
| Special income (charges) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Income before tax | -125.59%-437.02K | -12.58%-227.52K | 59.26%-123.02K | 37.67%-886.14K | -28.72%-188.34K | 49.89%-193.72K | 23.32%-202.09K | 51.71%-301.99K | -544.02%-1.42M | -138.75%-146.32K |
| Income tax | 0 | 0 | 0 | 50.70%-91.82K | 0 | 98.97%-590 | 16.88%-27.16K | 13.42%-64.07K | -186.25K | -22.17K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -126.28%-437.02K | -30.06%-227.52K | 48.30%-123.02K | 35.71%-794.33K | -51.70%-188.34K | 41.33%-193.13K | 24.23%-174.93K | 56.85%-237.92K | -459.66%-1.24M | -132.88%-124.16K |
| Net income continuous operations | -126.28%-437.02K | -30.06%-227.52K | 48.30%-123.02K | 35.71%-794.33K | -51.70%-188.34K | 41.33%-193.13K | 24.23%-174.93K | 56.85%-237.92K | -459.66%-1.24M | -132.88%-124.16K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -126.28%-437.02K | -30.06%-227.52K | 48.30%-123.02K | 35.71%-794.33K | -51.70%-188.34K | 41.33%-193.13K | 24.23%-174.93K | 56.85%-237.92K | -459.66%-1.24M | -132.88%-124.16K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -126.28%-437.02K | -30.06%-227.52K | 48.30%-123.02K | 35.71%-794.33K | -51.70%-188.34K | 41.33%-193.13K | 24.23%-174.93K | 56.85%-237.92K | -459.66%-1.24M | -132.88%-124.16K |
| Diluted earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | -255.49%-0.01 | 0 |
| Basic earnings per share | 0 | 0 | 0 | 0.00%-0.01 | -0.01 | 0 | 0 | 0 | -255.49%-0.01 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.